Suchergebnisse - "Ravetch, Jeffrey V"

PubPharm (394)

11

Antibodies to CD40 with enhanced agonist activity

enthalten in: Europäisches Patentamt | 2023

von RAVETCH JEFFREY V | DAHAN RONY

12

IL-15 synergizes with CD40 agonist antibodies to induce durable immunity against bladder cancer

enthalten in: Proceedings of the National Academy of Sciences of the United States of America | 2023

von Wong, J. | Smith, P. | Angulo-Lozano, J. | +6

UpdateOf: bioRxiv. 2023 Feb 01;:. - PMID 36778311

13

Human FcγRIIIa activation on splenic macrophages drives dengue pathogenesis in mice

enthalten in: Nature microbiology | 2023

von Yamin, R. | Kao, K. | MacDonald, M. | +4

14

enthalten in: Europäisches Patentamt | 2023

von RAVETCH JEFFREY V | WANG TAIA | MAMAARY JAD

15

enthalten in: Europäisches Patentamt | 2023

von RAVETCH JEFFREY V | WANG TAIA | MAMAARY JAD

16

The Antitumor Activities of Anti-CD47 Antibodies Require Fc-FcγR interactions

enthalten in: bioRxiv : the preprint server for biology | 2023

von Osorio, J. | Smith, P. | Knorr, D. | +1

UpdateIn: Cancer Cell. 2023 Nov 16;:. - PMID 37977147

17

Mechanism of glycoform specificity and in vivo protection by an anti-afucosylated IgG nanobody

enthalten in: Nature communications | 2023

von Gupta, A. | Kao, K. | Yamin, R. | +6

UpdateOf: bioRxiv. 2023 Jan 24;:. - PMID 36747840

18

Polypeptides With Enhanced Anti-Inflammatory And Decreased Cytotoxic Properties And Relating Methods

enthalten in: Europäisches Patentamt | 2023

von RAVETCH JEFFREY V | KANEKO YOSHIKATSU | NIMMERJAHN FALK

19

Polypeptides With Enhanced Anti-Inflammatory And Decreased Cytotoxic Properties And Relating Methods

enthalten in: Europäisches Patentamt | 2023

von RAVETCH JEFFREY V | KANEKO YOSHIKATSU | NIMMERJAHN FALK

20

COMBINATION OF ANTI-CD40 ANTIBODY AND IL-15 FOR TREATING CANCER

enthalten in: Europäisches Patentamt | 2023

von RAVETCH JEFFREY V | WONG JEFFREY | KNORR DAVID